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The autonomous goose parvovirus (GPV) and the human helper-dependent adeno-associated virus type 2 (AAV2) share a high degree of
homology. To determine if this evolutionary relationship has a biological impact, we studied viral replication in human 293 cells and in
embryonated goose eggs coinfected with both viruses. Similar experiments were performed with the minute virus of mice (MVM), an
autonomous murine parvovirus with less homology to AAV2. In human 293 cells, both GPV and MVM augmented AAV2 replication. In
contrast, AAV2 markedly enhanced GPV replication in embryonated goose eggs under conditions where a similar effect was not observed
with MVM. AAV2 did not replicate in embryonated goose eggs and AAV2 inactivated by UV-irradiation also enhanced GPV replication. To
our knowledge, this is the first report that a human helper-dependent member of the Parvoviridae can provide helper activity for an
autonomous parvovirus in a natural host.
D 2005 Elsevier Inc. All rights reserved.Keywords: Parvoviridae; AAV2; GPV; MVM; Coinfection; Embryonated goose eggs; 293 cellsIntroduction
The Parvoviridae is a large family of small single-
stranded DNA viruses that have been isolated from a wide
range of hosts extending from mammals through birds,
reptiles, and insects down to crustaceans. At present, the
Parvoviridae is divided into subfamilies and genera, depend-
ing mainly on host range and whether or not viral replication
is autonomous or helper-dependent (for a review, see
Muzyczka and Berns, 2002). The goose parvovirus (GPV),
the muscovy duck (MDPV), and the barbarie duck (BDPV)
parvoviruses have been classified as autonomous since they
are capable of independent replication in rapidly-growing
tissues of goslings and ducklings. In young waterfowl, these0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.03.019
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importance (Gough, 2003). Unexpectedly, the sequence of
the GPV, MDPV, and BDPV DNA genomes revealed a high
level of homology to that of the apathogenic, ubiquitous,
human adeno-associated virus serotype 2 (AAV2) (Brown et
al., 1995; Zadori et al., 1995). This finding was surprising,
since AAV2 is classified as belonging to a separate genus
(Dependovirus in the subfamily Parvovirinae) to reflect the
fact that its replication in human cell culture depends on
coinfection with an unrelated virus (usually an adenovirus or
a herpesvirus) or on exposure of the cell to genotoxic stress
(Muzyczka and Berns, 2002).
The GPV genome is a 5106-nucleotide single-stranded
DNA and the strands of both polarities are encapsidated
(Zadori et al., 1994, 1995). The genome comprises two
open reading frames, encoding regulatory and structural
proteins, bordered by identical inverted terminal repeats of
444 nucleotides that can fold into a U-shaped hairpin by
base pairing. At the DNA sequence level, the overall
homology between GPV and AAV2 was estimated to be05) 265 – 273
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overall similarity was estimated to be 61.7% for the
regulatory proteins and 70.2% for the structural VP1
proteins (Zadori et al., 1995). These levels of homology
are much higher than those exhibited by the mammalian
autonomous parvoviruses. Based on a comparison of 32
sequenced members of the Parvoviridae, Lukashov and
Goudsmit (2001) have proposed that primate AAV serotypes
1–6 and the waterfowl parvoviruses GPV, MDPV, and
BDPV evolved from a common ancestor and should be
reclassified as a single, distinct evolutionary group. Interest-
ingly, the regulatory proteins of chicken AAV (an avian
dependovirus) display 46–54% homology to those of
human AAV2 and approximately the same level of similarity
to those of GPV, suggesting that chicken AAV is equally
divergent from both viruses (Bossis and Chiorini, 2003).
The domains and functional elements of the regulatory
proteins of GPV (Rep1) and AAV2 (Rep78) have been
compared in detail by Smith et al. (1999) and Yoon et al.
(2001). The central cores of Rep1 and Rep78 share 67%
amino acid sequence identity; the amino termini display
37% identity and the carboxy termini display 22% identity.
These authors have identified a 38-nucleotide sequence in
the GPV terminal repeat that functions as an origin of
replication in cell-free reactions primed by GPV Rep1
protein and extracts of uninfected HeLa cells. In such
reactions, GPV Rep1 protein did not promote efficient
replication from the AAV2 origin sequence and AAV2
Rep78 did not facilitate efficient replication from the 38-
nucleotide GPV origin. Switching the 200 residues at the
amino terminal domains of the two regulatory proteins (that
is, replacing the amino terminal domain of Rep 78 with that
of Rep1 and vice versa) restored the initiation of DNA
synthesis by the corresponding regulatory protein (Yoon et
al., 2001). Hence, despite the amino acid sequence identities
between the GPV and AAV2 regulatory proteins, each
protein exhibits a clear preference for its cognate viral
origin.
The purpose of the present experiments was to determine
if the homology between GPV and AAV2 might have a
biological impact. To this end, we studied the consequences
of GPV/AAV2 coinfections in human 293 cells and in
embryonated goose eggs. The latter are the permissive hosts
for efficient GPV replication. In contrast to 293 cells, where
GPV enhanced AAV2 replication, we found that AAV2
strongly augmented the replication of GPV in the embryo-
nated egg under certain conditions. The possible mechanism
and significance of this unexpected AAV2-mediated helper-
effect for GPV will be discussed.Results
In the following experiments, we coinfected human 293
cells, or embryonated goose eggs, with AAV2 and GPV, and
asked if coinfection enhanced the replication of either virus.Coinfections with the minute virus of mice (MVM), an
autonomous mammalian parvovirus with a much lower
level of homology to AAV2 (Lukashov and Goudsmit,
2001), were performed in parallel to see if any enhancement
or potentiation of viral replication was correlated with the
degree of homology between the coinfecting viruses.
GPV and MVM coinfections enhance AAV2 DNA
amplification in 293 cells
To establish base lines for the coinfection experiments,
we first investigated the ability of AAV2 and GPV to
amplify their DNAs in separate infections of 293 cells.
Since previous work had shown that GPV replication in
cultures of primary goose embryo fibroblasts was confined
to DNA-synthesizing cells, and that optimum yields were
obtained when cell suspensions were exposed to virus
before plating for cell adherence (Kisary, 1979), we
adopted the same protocol for the infection of 293 cells.
Freshly trypsinized cells, from subconfluent cultures, were
resuspended in medium, mixed with virus, and then plated
for cell adherence and growth, as described in Materials
and methods. AAV2, GPV, and MVM amplified their
DNA in 293 cells, although to different extents (Fig. 1).
The amount of AAV2 DNA at 116 h post-infection (h p.i.)
(infection refers to the time when the suspended cells and
virus were mixed together) was 9.5-fold greater than at
20 h p.i. (Fig. 1A). GPV DNA at 94 h p.i. was 165-fold
greater than at 20 h p.i. (Fig. 1B); and MVM DNA at 72 h
p.i. was 300-fold greater than at 10 h p.i. (Fig. 1C). Thus,
the autonomous parvoviruses GPV and MVM amplified
their DNAs to higher levels than that shown by AAV2.
The multiplicities of GPV and MVM infections (1–3 IU/
cell) were much lower than those used for AAV2 (100 IU/
cell) and it was observed that even at these low multi-
plicities, GPV and MVM arrested the growth of 293 cells
(MVM also induced a cytopathic effect). When known
numbers of GPV-infected cells (multiplicity of 2 IU/cell)
were trapped on nitrocellulose filters that were subse-
quently hybridized with 32P-labelled GPV DNA, approxi-
mately 10% of the infected population were detected as
virus DNA-synthesizing cells after autoradiography (data
not shown).
Having established the base lines for separate infec-
tions, we then investigated the consequences of coinfec-
tion. As shown in Fig. 2A, GPV coinfection enhanced
AAV2 DNA amplification in 293 cells by a factor of 6.5
compared to AAV2 infection by itself. Southern blot
analysis of the AAV2 DNA at 72 h after coinfection
confirmed that both monomeric and multimeric replicative
intermediates had been amplified (data not shown). GPV
DNA amplification in cells coinfected with AAV2 was
reduced by half (Fig. 2B). Coinfected MVM also enhanced
AAV2 DNA amplification, though to a lesser extent: 2.3-
fold at 72 h and 1.3-fold at 95 h p.i., relative to AAV2
infection alone (Fig. 2C).
Fig. 1. AAV2, GPV, and MVM amplify their DNAs in 293 cells. 300,000
cells/ml were mixed with (A) AAV2 (100 IU/cell), (B) GPV (1 IU/cell), or
(C) MVM (3 IU/cell) and shaken at room temperature for 12 min. The
mixtures of cells and viruses were then plated and incubated at 37 -C for
cell adherence and growth. At the time intervals shown in the x-axis, the
cells were lysed and their viral DNA content determined by hybridization
with the 32P-labelled virus DNA probes designated in the y-axis. The y-axis
values are cpm 32P-DNA hybridized and are the average of duplicate
samples (error bars show standard deviations).
Fig. 2. GPV and MVM coinfections enhance AAV2 DNA amplification in
293 cells. In A, 293 cells were infected with AAV2 (100 IU/cell) or
coinfected with AAV2 plus GPV (1 IU/cell) and analyzed for AAV2 DNA
amplification at the times indicated. In B, samples of 293 cells infected as in
A were analyzed for GPV DNA amplification. In C, the cells were infected
with AAV2 (100 IU/cell) or coinfected with AAV2 plus MVM (3 IU/cell)
and analyzed for AAV2 DNA amplification. The conditions for infection,
plating of infected cells, and assay of virus DNA amplification were as
described in the legend to Fig. 1 and in Materials and methods.
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AAV2 progeny virions
We next asked if the enhancement of AAV2 DNA
replication in 293 cells coinfected with GPVor MVM leads
to the production of progeny virions. For these experiments,
clarified lysates of the infected 293 cells were titrated for
AAV2 virions by an in situ hybridization focus assay in
HeLa cells infected with adenovirus 5 (Yakobson et al.,1989). The results are shown in Fig. 3. Infection of
suspended 293 cells with AAV2 alone produced a small
yield of progeny virions (day 3 yield/day1 yield = 2.6),
confirming previous reports that 293 cells permit low levels
of independent AAV2 replication (Ogston et al., 2000;
Wang and Srivastava, 1998). By comparison, coinfection
with GPVor MVM gave rise to enhanced AAV2 yields: the
yield of AAV2 infectious units recovered on day 3 p.i. from
Fig. 3. AAV2 progeny yields in 293 cells are enhanced by coinfection with
GPVor MVM. Cells were mixed with AAV2 (1 IU/cell) or AAV2 plus GPV
(GPV at 6 IU/cell) or AAV2 plus MVM (MVM at 8 IU/cell), plated, and
incubated at 37 -C. At the time intervals shown (day 1 = 24 h after plating),
the cells were disrupted and the lysates titrated for infectious AAV2 by the
HeLa/Ad5 in situ hybridization focus assay, as described in Materials and
methods. The values shown are the total cell-associated AAV2 yields from
one dish of 300,000 cells.
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than the number recovered from cells infected with AAV2
alone. Similarly, MVM coinfection enhanced the AAV2
yield on day 3 by a factor of 7.1. In another experiment, the
AAV2 yield from cells coinfected with GPV was enhanced
8-fold on day 4 p.i., and that from cells coinfected with
MVM was enhanced 16-fold on day 4 p.i. (values relative to
the yields of cells infected with AAV2 alone). Thus,
although the homology between GPV and AAV2 is greater
than that between MVM and AAV2 (Lukashov and
Goudsmit, 2001), MVM as well as GPV was found capable
of augmenting AAV2 replication in 293 cells. The AAV2
progeny produced in 293 cells coinfected with GPV was
neutralized by polyclonal anti-AAV2 antiserum and not by
polyclonal anti-GPV antiserum (Table 1). Despite the 70%
similarity between the amino acid sequences of the AAV2
and GPV VP1 structural proteins (Zadori et al., 1995), no
cross-neutralization by polyclonal antisera was detected.Table 1
Anti-serum sensitivity of yields produced in infected and coinfected 293
cellsa
Infection Antisera No. of foci
AAV2 none 1060
anti-AAV2 0
AAV2 + GPV none 8400
anti-AAV2 0
anti-GPV 9100
AAV2 + MVM none 16,800
anti-AAV2 0
a 4-day yields of 293 cells, infected as above, were mixed with anti-AAV2
or anti-GPVantisera or PBS (‘‘none’’) and then titrated for infectious AAV2
by the in situ hybridization focus assay in HeLa cells infected with
adenovirus 5.An in situ hybridization focus assay for the titration of GPV
on 293 cells
The current titration of GPV is based upon embryo
mortality in embryonated goose eggs (Gough, 1998) or,
where the virus has been adapted to cell culture, an assay
based on cytopathogenicity in primary cultures of goose
embryo fibroblasts can be exploited (Kisary, 1979). The
Malkinson strain of GPV used in our studies was not
adapted for growth in cell culture and neither virus
replication nor cytopathogenicity was detectable in cultures
of primary goose embryo fibroblasts. In view of this, and
because embryonated goose eggs were not always available,
we developed an alternative assay based upon the finding
that GPV DNA is amplified in 293 cells (Fig. 1B). This
procedure is a modification of the HeLa cell in situ
hybridization focus assay for detecting cells synthesizing
AAV2 DNA (Yakobson et al., 1989). Suspensions of 293
cells infected with GPV dilutions were plated for cell
attachment and growth to monolayers. After 6-day incuba-
tion, the cell sheets were transferred intact to nitrocellulose
filters, hybridized to a 32P-labelled GPV DNA probe, and
cells replicating GPV DNA (foci) were visualized by
autoradiography. The development of foci was time-depend-
ent, reaching a maximum number at 6 days p.i., at which
time the dosage–response curve was linear up to 70
countable foci per 4.7 cm nitrocellulose filter (Fig. 4). The
foci were neutralized by anti-GPV polyclonal antiserum
(Fig. 5). The autoradiographic intensity of the GPV foci on
293 cells was uneven, suggesting that some cells synthe-
sized more GPV DNA than others (Fig. 5). However, even
when counts were restricted to prominent foci, the GPV titer
determined by the 293 in situ hybridization focus assay was
comparable to that determined by scoring for mortality in
embryonated goose eggs inoculated with limiting virus
dilutions. Hence, the 293 in situ hybridization focus assay
can be used to titrate GPV field isolates directly, without
prior adaptation of the virus to cell culture. Accordingly, this
assay was used to quantify GPV replication in ovo.Fig. 4. The GPV in situ hybridization focus assay in 293 cells: dosage
response. Microliters of a 104 dilution of a purified GPV stock were mixed
with a suspension of 300,000 cells/ml and plated for cell adherence and
growth. After 6 days of incubation, the cell monolayers were transferred to
nitrocellulose filters which were hybridized with a 32P-labelled GPV DNA
probe and autoradiographed. Foci were counted after an exposure of 96 h at
70 -C.
Table 2
AAV2 co-inoculation enhances GPV replication in embryonated goose
eggsa
Exp Inoculum Egg Dayb Yield of GPV (IU/ml)  102
AF Embryo
I GPV 3A 6 (d) 240 ND
GPV 3B 3 (d) 30 ND
GPV + AAV 13A 6 (s) 9000 ND
GPV + AAV 13B 6 (s) 8000 ND
II GPV 24A 1 (s) 60 1
GPV 24B 7 (s) 39 1
GPV 25A 7 (s) 450 10
GPV 25B 7 (s) 40 10
GPV + AAV 28A 6 (d) 52,000 46,000c
GPV + AAV 28B 7 (s) 16,000 74,000
GPV + AAV 28C 7 (d) 4000 68,000
a Embryonated goose eggs (Israeli source) were inoculated with 1000 IU of
GPV alone or 1000 IU of GPV supplemented with 1  108 IU of AAV2
(GPV + AAV). At the day indicated, the amount of GPV in the amnio-
allantoic fluid (AF) or the embryo extract (Embryo) was titrated by the in
situ hybridization focus assay in 293 cells. ND, not done.
b Day (post-inoculation) of harvest and state of embryo: (d), dead; (s),
survived.
c At a 105 dilution, the foci were neutralized by anti-GPV antiserum
diluted 103.
Fig. 5. The GPV in situ hybridization focus assay in 293 cells:
neutralization by antisera. Cells were mixed with an appropriate dilution
of GPV or GPV supplemented with a 1:1000 dilution of polyclonal goose
anti-GPV antiserum (abGPV) or a 1:100 dilution of polyclonal rabbit anti-
AAV2 antiserum (GPV + abAAV) or a 1:100 dilution of preimmune rabbit
serum (GPV + preimmune). After 12 min at room temperature, the mixtures
were seeded into culture dishes and incubated at 37 -C. Six days later, the
cell monolayers were transferred to nitrocellulose filters and cells
synthesizing GPV DNA were visualized by hybridization and autoradio-
graphy. The numbers in brackets refer to the number of GPV-positive cells
(foci) counted.
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eggs
We next investigated the GPV/AAV2 interaction in
embryonated goose eggs, the permissive host system for
the isolation of GPV field isolates and for the commercial
production of a GPV live virus vaccine (Gough, 1998, 2003;
Tater-Kis et al., 2004). Two sources of embryonated goose
eggs were available. One batch was from an Israeli goose
farm whose flocks were not certified to be free of GPV and
the second source was a United Kingdom (UK) commercial
supplier of embryonated goose eggs from flocks certified to
be free of GPV.
The embryonated goose eggs from the Israeli source
were poor hosts for the replication of GPV. At an input of
1000 IU of GPV inoculated per egg, the yields after 7 days
of incubation were either lower or only 4-fold greater than
the day 1 yield (Table 2, eggs 24A, 24B, 25A, and 25B).
Unexpectedly, however, we found that supplementing the
GPV inoculum with a 100,000-fold excess of AAV2
resulted in a striking enhancement of the GPV yield. In 2
independent experiments, the augmentation of the GPV
yield, resulting from the co-inoculation of AAV2, rangedfrom 30-fold up to several thousand-fold (Table 2). The
yields from the co-inoculated eggs were neutralized by anti-
GPV antiserum in the 293 cell in situ hybridization focus
assay (footnote c).
The embryonated goose eggs from the UK flock that
was certified to be free of GPV were much more permissive
for GPV replication. At an input inoculation of 1000 IU of
GPV, yields of 2–10 million IU/ml were obtained at 4 days
post-inoculation. However, co-inoculation with a 100,000-
fold excess of AAV2 produced no detectable enhancement
of the GPV yield (data not shown). We assumed that at an
input of 1000 IU of GPV per highly permissive egg, the
yield was at a near maximum level such that any enhance-
ment due to co-inoculated AAV2 might not be detectable.
To test this assumption, we reduced the input level of GPV
inoculated to a near limiting dilution of 10 IU/egg. Under
these conditions, the addition of a 10 million-fold excess of
AAV2 to the inoculum enhanced the GPV yield 3- to 100-
fold (Table 3). It is noteworthy that co-inoculation with a
similar excess of MVM produced no enhancement of the
GPV yield. Importantly, UV-inactivated AAV2 enhanced
the GPV yield in 2 out of the 3 co-inoculated eggs (9B and
9C in Table 3) to a level that was comparable to that
induced by co-inoculating the same excess of AAV2 prior
to UV-inactivation.
There was no evidence for AAV2 replication in
embryonated goose eggs. As shown in Table 4, the yields
over a 6- to 7-day incubation period in eggs inoculated with
108 IU of AAV2 were no higher than the day 1 yields, as
determined by the in situ hybridization focus assay in HeLa
cells coinfected with adenovirus. Dot-blot hybridization
assays for measuring AAV2 DNA levels in amnio-allantoic
Table 3
GPV replication in embryonated goose eggs is enhanced by AAV2 and by
UV-inactivated AAV2 but not by MVMa
Exp Inoculum Egg Dayb Yield of GPV
(IU/ml)  104
IV GPV 3A 5 (s) 2
3B 3 (d) 2
3C 5 (s) 58
GPV + AAV 6A 5 (s) 240
6B 5 (s) 182
6C 5 (s) 230
GPV + AAV/UV 9A 5 (s) 88
9B 5 (s) 200
9C 5 (s) 210
GPV + MVM 12A 5 (s) 2
12B 5 (s) 4
12C 5 (s) 66
a Embryonated goose eggs (from a UK supplier) were inoculated either
with 10 IU of GPV alone or 10 IU of GPV supplemented either with 1 
108 IU of AAV2 (GPV + AAV) or 1  108 IU of AAV2 inactivated by UV-
irradiation (GPV + AAV/UV) or 1  108 IU of MVM (GPV + MVM). At
the day indicated, the amount of GPV in the embryo extract was determined
by the in situ hybridization focus assay in 293 cells.
b Day (post-inoculation) of harvest and state of embryo: (d), dead; (s)
survived.
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DNA amplification (data not shown) and no embryo
mortality resulted from the infection (Table 4). Hence, the
AAV2-mediated enhancement of GPV replication in
embryonated goose eggs does not depend upon AAV2
replication. This conclusion is further supported by the
finding that UV-irradiated AAV2 (infectivity reduced by 6
logs) also enhanced GPV replication.Table 4
AAV2 does not replicate in embryonated goose eggsa
Exp Egg Dayb Yield of AAV2 (IU/ml)  105
AF Embryo
II 22A 1 (s) 4 <1c
23A 7 (s) 5 <1c
III 3B 1 (s) 80 1
4A 6 (s) 44 <1c
4B 6 (s) 18 1
a Embryonated goose eggs (Israeli source in Exp II, UK source in Exp III)
were inoculated with 1  108 IU of AAV2. At the day p.i. indicated, the
amount of AAV2 in the amnio-allantoic fluid (AF) and embryo extract
(Embryo) was titrated by the in situ hybridization focus assay in HeLa cells
infected with adenovirus 5.
b Day post-inoculation of harvest and state of embryo: (s), survived.
c No foci seen at 105 dilution.Discussion
The division between the autonomous parvoviruses and
helper-dependent AAV is not sharply delineated. Low levels
of independent AAV2 replication have been reported to
occur in cell lines exposed to genotoxic agents (Schlehofer
et al., 1986; Yakobson et al., 1987, 1989; Yalkinoglu et al.,
1988), in human 293 cells which express the adenovirus E1
genes constitutively (Ogston et al., 2000; Wang and
Srivastava, 1998), and in primary keratinocytes differ-
entiating in a human skin model (Meyers et al., 2000). In
parallel, the replication of autonomous parvoviruses such as
GPV and H1 is not always totally independent and can be
potentiated or enhanced in cell culture by coinfection with
an unrelated helper virus (Kisary, 1979; Toolan, 1972).
Since, among the autonomous parvoviruses, GPV is the
closest relative of AAV2 (Lukashov and Goudsmit, 2001),
we were interested in whether GPV or AAV2 might induce
an activity that enhances the replication of either virus in a
coinfection.
In human 293 cells, we observed that both GPV and
MVM amplified their DNAs, aborted cell division, and
significantly enhanced the replication of AAV2. It ispossible that this enhancement is connected with the
imposition of cellular stress, resulting from a cessation of
cell-cycle progression, a condition that is known to enhance
permissiveness for independent AAV2 replication in some
cell lines (Yakobson et al., 1987, 1989). Even at the
relatively low multiplicities of MVM and GPV infections
used (1–3 IU/cell), the growth of 293 cells was impaired.
Similar effects were obtained by coinfecting AAV2 with
either GPV (closely related to AAV2) or MVM (much less
closely related to AAV2), indicating that the enhancement of
AAV2 replication is not correlated with the degree of
homology between coinfecting viruses. Nevertheless, the
possibility cannot be excluded that, in 293 cells, the GPV
helper effect for AAV2 operates via a separate pathway from
that of MVM.
Our studies on the consequences of co-inoculating
embryonated goose eggs with GPV and AAV2 produced
an unexpected result. Embryonated goose eggs are, in
general, an effective host system for the productive
replication of GPV (for reviews, see Gough, 1998, 2003).
However, under conditions where GPV replication was
impaired in a given batch of eggs, or under conditions where
a limiting input multiplicity of GPV was used, co-
inoculation with a large excess of AAV2 resulted in a
striking increase in the GPVyield. This is the first report that
a dependovirus can provide helper activity for an autono-
mous parvovirus in a natural host. A clue to the possible
mechanism is provided by the observation that UV-
inactivated AAV2 also enhanced GPV replication in ovo.
There are several precedents for the finding that UV-
inactivated AAV2 is still capable of inducing a host
response. For example, UV-inactivated AAV2 induces
cell-cycle arrest in mammalian cells (Winocour et al.,
1988), stimulates apoptosis in p53-deficient cells (Raj et
al., 2001), and triggers a cellular response which mimics the
signal set off by a stalled DNA replication fork (Jurvansuu
et al., 2005). Part of the mammalian cellular response to
infection by both live and UV-inactivated AAV2 has been
attributed to the single-stranded configuration and hair-
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2005; Raj et al., 2001). Such DNA configurations may be
sensed by the cell as damaged DNA, which is known to
stimulate the production of DNA repair enzymes (Huang et
al., 1996 and references therein). Furthermore, it has been
suggested that the host response to damaged DNA may be
an integral component of the early AAV2 infectious process,
required to stimulate host events necessary for intracellular
trafficking, uncoating, and conversion of the uncoated AAV
DNA into a transcriptionally active, duplex DNA template
(Hauck et al., 2004). GPV replication in goose embryo
fibroblasts in culture is confined to DNA-synthesizing cells,
while in quiescent cells, GPV replication requires the helper
activity of a coinfecting duck plague herpesvirus (Kisary,
1979). We propose, therefore, that early events in the GPV
infection of goose embryo cells require the stimulation of
cellular processes akin to those induced by live and
inactivated AAV2 virions in mammalian cells.
The input ratio of AAV2 to GPV is an important factor
which influences the outcome of the co-inoculation. On the
basis that a 10-day-old embryonated chick egg contains 108
cells (Vogt, 1969), we estimate that the larger 10- to 12-day-
old goose eggs used in our experiments contained consid-
erably more than 108 cells. When the input multiplicity of
GPV is low (to facilitate the detection of yield enhance-
ment), a large excess of AAV2 is required to ensure that the
small number of cells infected with GPV are also infected
with AAV2. Furthermore, if the helper activity of AAV2 is
mediated primarily by the incoming parental DNA, as
proposed above, then a high input multiplicity will be
required to provide a sufficiency of single-stranded DNA
molecules per cell.
In addition to the proposal that the helper effect for GPV
replication in ovo is due to an AAV2-mediated induction of
a cellular response to damaged DNA, the question remains
if the homology between GPVand AAV2 plays a role in this
activity. That the homology might play a role is suggested
by the observation that MVM, an autonomous parvovirus
with a much lower degree of genomic homology to GPV,
did not enhance GPV replication in the embryonated goose
egg. However, additional studies on mixed infections in ovo
with GPV and other parvoviruses will be necessary to
establish that the AAV2 helper effect for GPV in goose eggs
is indeed specific to AAV2 and reflects an avian evolu-
tionary origin for this virus.Materials and methods
Viruses and antisera
The Malkinson strain of GPV is a field isolate that was
passaged 4 times on embryonated goose eggs (Malkinson et
al., 1974). Crude virus in amnio-allantoic fluids of infected
embryonated goose eggs (a generous gift of ABIC Ltd, Beit
Shemesh, Israel) was purified by differential centrifugationand equilibrium centrifugation in cesium chloride density
gradients. Briefly, the amnio-allantoic fluids were clarified
at 10,000 rpm in a Sorval SS-34 rotor. Virus in the
supernatant was sedimented at 40,000 rpm for 3 h at 4 -C
(Ti45 Spinco rotor) and resuspended in Tris-EDTA (pH 8.0)
(1/50th of the starting volume) by rotation at 4 -C for 48 h.
Cesium chloride was then added to obtain a refractive index
of 1.3720 (density 1.40 g/cm3) and the virus was banded by
equilibrium centrifugation in a SW50.1 Spinco rotor at
38,000 rpm for 24 h at 20 -C. Fractions of the gradient
were assayed for refractive index and content of GPV DNA
by dot-blot hybridization with a GPV-specific plasmid-
cloned DNA probe (Brown et al., 1995; a gift from Dr
Kevin Brown). Fractions with a refractive index in the
range 1.3730–1.3714 (densities 1.413–1.395 g/cm3) con-
tained most of the virus. These fractions were pooled and
diluted 10-fold with sterile water. The virus was recovered
by sedimentation (SW50.1 rotor, 40,000 rpm, 2.5 h at
10 -C), re-suspended in sterile water by rotation at 4 -C
overnight, and stored at 20 -C. Starting with 100 ml of
infected amnio-allantoic fluids, 1 ml of purified GPV
containing 3  108 infectious units was obtained by this
procedure. Anti-GPVantiserum was derived from the serum
of a vaccinated goose.
AAV2 stocks, grown from a cloned plasmid, were
purified on cesium chloride gradients and titrated by the
in situ hybridization focus assay on HeLa cells coinfected
with adenovirus 5 (Yakobson et al., 1987, 1989). Where
indicated, AAV2 was inactivated by UV-irradiation (fluence
of 2500 J/m2) to a survival for infectious virus of less than
106 (Winocour et al., 1988). Anti-AAV2 antiserum was
prepared from the sera of mice infected with purified virus.
Minute virus of mice (MVM) was a gift of Dr. Jacov Tal.
Infection and virus assays in 293 cells
To investigate virus DNA amplification, freshly trypsi-
nized 293 cells, from a sub-confluent culture, were infected
in suspension by mixing 300,000 cells/ml in Dulbecco-
modified Eagles medium, containing 10% fetal calf serum,
with virus at the multiplicities indicated in figure legends
and tables. The mixture of cells and virus was shaken at
room temperature for 12 min, plated into 5-cm diameter
plastic dishes, and incubated at 37 -C for cell adherence
and growth. At the indicated times, the medium was
removed, the cells were lysed with 1.5 ml of Denaturation
Buffer (1.5 M NaCl, 0.5 N NaOH) and shaken at room
temperature for 24–48 h. Duplicate 50-Al samples of the
lysates (1/30th of the total) were applied to nitrocellulose
filters under suction. After neutralization and cross-linking
of the DNA by UV-irradiation, the filters were hybridized
with 32P-labelled viral genomic DNA probes, under
stringent conditions (Yakobson et al., 1987), and quantified
by scintillation counting.
To assay for the production of AAV2 progeny virions,
293 cells, infected as above, were scraped into the
M. Malkinson, E. Winocour / Virology 336 (2005) 265–273272medium, harvested by low speed centrifugation, re-
suspended in Iscove medium, and disrupted by 3 cycles
of freeze–thawing. After clarification (5000 rpm for 10
min), the amount of infectious AAV2 in the lysates was
determined by the in situ hybridization focus assay in
HeLa cells infected with adenovirus type 5 (Yakobson et
al., 1989).
For the titration of infectious GPV by an in situ
hybridization focus assay in 293 cells, appropriate
dilutions of the virus were mixed with 300,000 cells/ml
and shaken at room temperature for 12 min. The virus–
cell mixture was then seeded into 5-cm culture dishes and
incubated at 37 -C for cell adherence and growth. After 6
days, the cell monolayer was transferred physically intact
to nitrocellulose filters (Villarreal and Berg, 1977). The
cells on the filter were then denatured, neutralized, UV-
crosslinked, and hybridized with a GPV DNA probe
(DNA extracted from purified virions and labeled with 32P
in vitro) as described for the in situ hybridization focus
assay of AAV2. Cells synthesizing GPV DNA were
detected by autoradiography at 70 -C for 100 h. The
titer was then calculated from the number of positive cells
multiplied by the dilution factor and is expressed as
infectious units (IU) per ml. The validation of this assay
is described in Results.
Inoculation of embryonated goose eggs and harvest of virus
yields
Embryonated goose eggs were obtained from a local
commercial goose farm and from a UK supplier of
fertilized eggs from flocks certified to be free of GPV
(gift of ABIC Ltd, Beit Shemesh, Israel). Virus diluted in
Hanks buffer was inoculated, by the allantoic route
(Gough, 1998), into 10- to 12-day-old eggs. At the time
intervals noted in the Tables, the inoculated eggs were
chilled at 4 -C, and the amnio-allantoic fluids and the
embryos were harvested separately. The amnio-allantoic
fluids were clarified at 5000 rpm for 10 min and their GPV
content was determined by the in situ hybridization focus
assay in 293 cells described above and in Results. To
determine the amount of GPV in the embryonic tissues,
whole embryos, stored frozen at 70 -C, were cut into
small pieces and disrupted by grinding with glass beads
and 4 cycles of freeze–thawing. After clarification at 5000
rpm for 15 min, the supernatants were assayed for GPV
content as above. The amount of AAV2 in the amnio-
allantoic fluids and in the embryo extracts was determined
by the in situ hybridization focus assay in HeLa cells
infected with adenovirus 5.Acknowledgments
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